Potassium hydroxide 5% for the treatment of molluscum contagiosum.
Drug Ther Bull
; 52(10): 118-20, 2014 Oct.
Article
em En
| MEDLINE
| ID: mdl-25298120
ABSTRACT
Molluscum contagiosum is a common reason for consultation in primary care. The condition is normally benign and self-limiting1 and the standard advice is to wait for the lesions to resolve spontaneously.2 Recently, potassium hydroxide 5% (MolluDab-Alliance Pharmaceuticals Limited) has been marketed in the UK for the treatment of the condition.3 It is sold as a medical device rather than a licensed medicinal product. Here we consider the evidence for potassium hydroxide 5% in the management of molluscum contagiosum.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Compostos de Potássio
/
Hidróxidos
/
Molusco Contagioso
Limite:
Humans
Idioma:
En
Revista:
Drug Ther Bull
Ano de publicação:
2014
Tipo de documento:
Article